DEFA14A: Apogee Therapeutics Sets Date for 2024 Annual Meeting, Outlines Voting Matters

Apogee Therapeutics has scheduled its 2024 Annual Meeting for June 5, 2024, and is soliciting votes on key proposals including the election of directors and ratification of the company's independent auditor.

Summary

• Apogee Therapeutics, Inc. will hold its Annual Meeting on June 5, 2024.
• Stockholders are being asked to vote on the election of three Class I directors for terms expiring in 2027: Andrew Gottesdiener, M.D., Peter Harwin, and Michael Henderson, M.D.
• Another proposal involves the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2024.
• Additionally, stockholders will vote on the approval of granting options to purchase 100,000 shares of the company's common stock to director Mark C. McKenna.
• The proxy materials are available online, and stockholders can request a paper or email copy before May 22, 2024.

Sentiment

Score: 7

Explanation: The document is a routine proxy statement, indicating standard corporate governance procedures. The sentiment is neutral to slightly positive as it reflects the company's engagement with its shareholders.

Positives

• The company is providing multiple avenues for stockholders to access proxy materials and vote, including online access and the option to request paper or email copies.
• The proposals are clearly outlined, allowing stockholders to make informed decisions.

Future Outlook

The document outlines the matters to be voted on at the upcoming annual meeting, providing insight into the company's governance and operational decisions for the coming year.

Industry Context

This announcement is a standard part of corporate governance, ensuring that shareholders have the opportunity to participate in key decisions regarding the company's direction and oversight.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• The election of directors and ratification of the auditor are important for corporate governance and accountability.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold its Annual Meeting on June 5, 2024.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Ernst & Young, Apogee Therapeutics, Voting, Options